A 51-year old woman was admitted with multiple cerebral, pulmonary and intra-abdominal abscesses. The combination of apparent immunosuppression, obesity, diabetes mellitus, hypertension, hypokalaemia, osteoporotic fractures and bilateral shoulder avascular necrosis led to a clinical diagnosis of Cushing's syndrome (CS). This was biochemically confirmed as follows: midnight serum cortisol 4275 nmol/L (60-250), non-suppressed overnight dexamethasone suppression test, raised salivary cortisol 716 nmol/L (5-46) and ACTH 639 ng/L (0-46). Urinary free cortisol was elevated >75,000 nmol/L (<165). Urinary steroid metabolites measured by Gas Chromatography Mass Spectrometry were markedly increased: tetrahydrocortisol (THF) tumour and bilateral adrenal hyperplasia. Urinary 5HIAA was marginally raised with a normal chromogranin A. She underwent a thymectomy which confirmed a 'paraganglioid' variant of a thymic carcinoid tumour. We describe a case of ACTH-secreting thymic carcinoid that presented with florid clinical and biochemical features of CS, but no carcinoid syndrome. The of CS, although this was not the case in our patient. In this article we examine the degree to which the various urinary steroid metabolites were raised in this patient with florid CS and compare them with some normative data obtained from patients with either Cushing's disease or the normal population. We hereby postulate that steroid metabolomics profiling may be helpful in establishing the differential diagnosis of CS.
INTRODUCTION
Neuroendocrine tumours (NET) are rare tumours expression pattern characterized by deregulation of many bio-functions including abnormal proliferation and differentiation signals, which may be involved in the development of NETs. Other abnormalities, like activation of neuropeptide signalling and inhibition of immune responses, may explain the hormonal disorders and immunity defects evident in ectopic adrenocorticotropic hormone (ACTH) syndrome. 4 Thymic carcinoids are rare tumours that exhibit a predilection for men, with a 3:1 male to female ratio. 2, 5 In 30% of cases these tumours are usually an incidental finding on routine radiography. The tumours often show cytological and architectural features of neuroendocrine differentiation, hence can be positive for CD56, neuron-specific enolase, chromogranin, somatostatin and synaptophysin. 5 Most carcinoids are benign in behaviour, but thymic carcinoids display a much more aggressive phenotype and can be associated with ectopic ACTH syndrome, which in itself seems to be linked with poorer prognosis. [6] [7] It is unclear whether this latter correlation is due to metabolic complications secondary to Cushing's Syndrome (CS) or to inherently more aggressive tumour behaviour.
Urine steroid metabolomics make use of the differentiating expression of various steroid metabolites [Gas Chromatography Mass Spectrometry (GC/MS)] in order to try and distinguish between various conditions. It is an evolving field and has been applied for example to discriminate between benign and malignant adrenal tumours 8 for early detection of recurrence of adrenocortical carcinoma 9 and for the differential diagnosis of primary hyperaldosteronism. 10 Here, we present a patient with ectopic CS where urine steroid metabolites were measured in an effort to determine whether there exists a specific metabolomic fingerprint for this rare condition.
CASE REPORT
A 51-year old lady was admitted with multiple cerebral, pulmonary and intra-abdominal abscesses. She was referred to the endocrine team because of newly-diagnosed type 2 Diabetes Mellitus. The combination of apparent immunosuppression, obesity (BMI 33.2 kg/m 2 ; 18-25), diabetes mellitus (HbA1c 8.5%; mmHg), hypokalaemia (K + 2.9 mmol/L; 3.5-5.0), osteoporotic fractures and bilateral shoulder avascular necrosis (BSAN) led to a clinical diagnosis of CS. This was biochemically confirmed by non-suppressed cortisol in an overnight dexamethasone suppression test, midnight serum cortisol 4275 nmol/L (60-250), raised midnight salivary cortisol 716 nmol/L (5-46) and ACTH 639 ng/L (0-46). Urinary free cortisol (UFC) was elevated in excess of 75,000 nmol/24h (<165) on two occasions. Urinary steroids metabolites were markedly increased (Table 1 ) and the relevance of these metabolites to the steroid metabolic pathway can be seen in Figure 1 . In particular, tetrahydrocortisol (THF) and tetrahydrocortisone (THE) were markedly raised at 219024 μg/24h (435-1709) and 88848 μg/24h
Given the markedly raised ACTH, cortisol and cortisol metabolites in association with hypokalaemia ectopic CS was more likely than Cushing's disease; indeed, given the computed tomography (CT) and positron emission tomography (PET) CT imaging appearances ( Figure 2 ) of a thymic tumour and normal pituitary magnetic resonance imaging, a diagnosis of ectopic CS due to a thymic NET was reached without needing to embark on the high-dose dexamethasone suppression test, corticotrophin-releasing hormone stimulation test or bilateral inferior petrosal sinus sampling (IPSS). Urine 5-hydroxyindoleacetic acid and chromogranin A was normal at 52 pmol/L (<60). Octreotide scanning showed increased focal activity in the thymus. Multiple Endocrine Neoplasia type 1 (MEN1) was deemed to be quite unlikely given that the calcium was normal (2.36 mmol/L; 2.1-2.6) and there was no evidence of other NETs seen on abdominal CT imaging (which showed appearances of bilateral adrenal hyperplasia) and fasting gut peptides were within normal limits. Genetic testing was not required, especially given that our patient did not have any family history suggestive of MEN1.
Given that this woman presented with gross CS she required stabilization before surgical resection. This included the use of multiple and recurrent courses of potent antibiotic, antiviral and antifungal medications in order to treat the underlying infections. Metyrapone was prescribed to treat hypercortisolaemia way that can include all steroid and urinary analytes described in Table 1 . Also, this pathway illustrates that one steroid metabolite can often be the product of one or more steroids in the biochemical pathway. and reduce progression of CS complications; her urinary steroid metabolite profile post-metyrapone and pre-operatively is given in Table 1 . Insulin was used to manage her hyperglycaemia. Potassium supplements, spironolactone and ramipril were given to achieve normotension and normokalaemia. Once the patient was rendered eucortisolaemic and haemodynamically and metabolically stable, she underwent thymectomy. Histology confirmed a paraganglioid variant of a thymic carcinoid tumour.
Post-operatively her 9am cortisol (off glucocorticoids) was below 50 nmol/L, which was indicative of disease remission. Thereafter, she displayed remarkable clinical and biochemical recovery, but poorly controlled diabetes, hypertension, obesity and BSAN continued to be active problems. She has now been in remission for the past five years.
DISCUSSION
We describe a case of ACTH-secreting thymic carcinoid that presented with florid clinical and biochemical features of CS. Profoundly elevated cortisol concentrations were observed in saliva, serum and urine, with loss of diurnal variation. Indeed, her UFC has possibly been the highest ever described. The markedly elevated total urinary excretion of cortisol in CS secondary to ectopic ACTH production was previously described. 11, 12 In one case of ACTH-secreting CS, the UFC was as high as 45000 nmol/24h despite treatment with octreotide or ketoconazole. 11 In a review of all thymic carcinoids over a 25-year period from the National Institute of Health (NIH) in the US, the medium and highest UFC observed were 5,890 and 13 Additionally, her detailed urine steroids analysis showed markedly high levels of cortisol and cortisone metabolites (THF and THE, respectively), which is pathognomonic for patients with CS. 14 The analysis of urinary steroids metabolites was performed using GC/MS in the Centre for Endocrinology, Diabetes and Metabolism in Birmingham. The exact methodology has previously been described. 8 approximately 1 is considered as normal. 15 involves an enzyme system that functions to catalyse the conversion of cortisol into cortisone; [16] [17] [18] (relevant gene is HSD11B1 on chromosome = 1q32-q41) is present in the liver, testis, lung, adipose tissue and is a reduction enzyme that converts cortisone on chromosome 16q22) is found in the kidneys and placenta and is a dehydrogenase enzyme that converts previously been shown to be significantly increased in CS regardless of aetiology. However, it has been observed as being markedly higher in patients with ectopic ACTH syndrome as compared to pituitarydependent CS (4.12 vs. 1.49, respectively; p <0.01) and inversely correlated with serum potassium levels. 14 In our case, the cortisol metabolites ratio was 2.8, which fell between the results mentioned above. To our knowledge, there are no definite cut-off values between Cushing's disease and ectopic ACTH syndrome. There is a degree of overlap between these should be interpreted with caution. Indeed, it has been noted that a ratio between 1 and 3 may still be considered as normal. Therefore, based on this value only it is impossible to make a diagnosis of CS or indeed to ascertain its aetiology (Norman Taylor, personal communication). The quantity of cortisol excretion and the rate of its excretion are very individual and vary between cases; the more florid CS is, the higher the UFC. Hence in our practice, we often interpret in this case) is of more clinical use and is usually indicative of CS (Norman Taylor, personal communialso been demonstrated to be clinically important in the diagnosis of hypertension caused by congenital after liquorice ingestion. 19 With excessive cortisol increase in the urine free cortisol to cortisone ratio and subsequently in the THF:THE ratio.
The inversion of the THF/THE ratio in our patient (Table 1) is likely due to a combination of increased florid hypercortisolaemia per se. Most of the glucocorticoid metabolites were profoundly decreased following treatment with metyrapone. It was surprisdid not increase upstream metabolites such as the androgens and tetrahydro-11-deoxycortisol ( Table  1 ). The mechanism of this remains unclear.
Our case demonstrates not only that glucocorticoid metabolites are markedly increased in Ectopic CS but also that mineralocorticoid and sex hormone metabolites are significantly increased as well ( Table  1 ). The various metabolites were increased to varying degrees in our own patient (Table 1) . A recent study has examined urinary glucocorticoid metabolites to provide biomarkers for the classification of adrenal incidentalomas and has provided median values for 48 normal controls and 26 patients with active (pituitary) Cushing's disease. 20 With reference to these data, glucocorticoid metabolites were massively increased in our patient compared to normal control values compared with patients with active Cushing's disof increase in the various glucocorticoid metabolites in our patient followed the same order whether the values were compared to normal controls or to Cushing's disease and obeyed the following incremental values for cortisol (Table 2 ). It should be emphasised that the analysis of urine steroids profile and serum cortisol were completed in different laboratories and as a result they have different units.
Approximately 200 cases of ACTH-secreting thymic carcinoid have been reported in the literature. 6, [11] [12] [13] [21] [22] [23] Thymic carcinoids, which are associated with CS, occur over a wide age range of 4 to 64 years and show no gender predilection. The most common features of CS are manifestations of tumours producing ectopic ACTH, with hypertension, oedema, severe hypokalemia and myasthenia being more common in ectopic ACTH-producing tumours than in Cushing's disease. 23, 24 Incomplete processing of ACTH precursors causing higher levels of pro-opiomelanocortin (POMC) have been described with ectopic ACTH, which has been proposed as a way of differentiating it from Cushing's disease. 25 We have previously shown that cross-reactivity of POMC in currently available 'ACTH' immunoassays varied from a mean of 1.6-4.7% which caused a large percentage increase in measured ACTH of up to 261%, 26 albeit we have not measured POMC in this particular patient. Our patient experienced various bacterial, fungal and viral infections and septicaemia that were disseminated in time and site and proved difficult to treat despite use of strong antibiotics, antiviral and antifungal agents and input from an on-site infectious disease team. It is possible that the accompanying hyperglycaemia has contributed to this phenomenon. Our case illustrates that hypercortisolaemia should be part of the differential diagnosis of acquired immunosuppression. Indeed, when 54 patients with ectopic ACTH production, but without lung cancer, were examined, it was shown that the more severe the hypercortisolaemia the more likely is the presence of severe infections (including sepsis); often these infections behaved atypically with no/mild fever and normal/near-normal white cell counts. 27 Once the tumour is successfully removed, lifelong surveillance involves similar investigations to those used for monitoring patients with CS i.e. UFC, ODST and/or salivary cortisol. Primary thymic NETs have a poor prognosis. This is due to the aggressive nature of the tumour with a high post-operative recurrence rate. Low-grade thymic carcinoids present a 5-year survival of 50% and 10-year survival of 9%, whereas high-grade thymic carcinoids have a 5-year survival of 0%. 5 Patients with tumour recurrence are likely to develop CS again and an important part of their management is controlling hypercortisolism, either with ketoconazole and/or metyrapone or bilateral adrenalectomy.
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CONCLUSION
This case demonstrates the biochemistry that one may expect to see with florid ectopic CS. It also emphasizes that one steroid metabolite can be the product of one or more steroids in the biochemical pathway, as was noted with various mineralocorticoid and sex hormone steroid metabolites that were raised in our case. Furthermore, it is conceivable that that urinary steroid metabolomics could be increasingly used in the near future for diagnosing ectopic CS as it seems to be associated with much higher urinary glucocorticoid metabolites than CS; similarly such metabolites may be useful for monitoring disease recurrence in ectopic CS.
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